# ELOX (Eloxx Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Eloxx Pharmaceuticals, Inc. reported $0 in revenue and a net loss of $15.84M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/ELOX
- Markdown: https://convexityos.com/fundamentals/ELOX.md
- SEC CIK: 0001035354
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001035354&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$17.55M | Operating profit |
| Net Income | FY 2025 | -$15.84M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.39 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $56.26M | Total debt: $0 |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $6.36M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $3.06M | $3.58M | $8.60M | $23.73M | $22.90M | $14.59M | $26.35M | $20.49M | $16.40M | $280K |
| Total Operating Expenses | $6.44M | $8.83M | $17.29M | $34.42M | $66.02M | $33.45M | $50.55M | $47.56M | $20.39M | -- |
| **Operating Income** | -$6.44M | -$2.47M | -$17.29M | -$34.42M | -$66.02M | -$33.45M | -$50.55M | -$47.56M | -$20.39M | -$2.21M |
| **EBITDA** | -$6.44M | -$2.43M | -$17.18M | -$34.34M | -$65.90M | -$33.39M | -$50.47M | -$47.35M | -$20.35M | -$2.17M |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | $43K | -- |
| Income Before Tax | -$6.00M | -$3.14M | -$17.05M | -$36.06M | -$66.73M | -$34.58M | -$50.87M | -$47.06M | -$21.21M | -$1.57M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $122K | -- | -$640K |
| **Net Income** | -$6.00M | -$3.14M | -$17.05M | -$36.06M | -$66.73M | -$34.58M | -$50.87M | -$47.19M | -$21.21M | -$934K |
| Basic EPS | -$0.49 | -$0.84 | -$6.63 | -$666.00 | -$1,526.00 | -$34.40 | -$53.60 | -$58.00 | -$190.00 | -$2.00 |
| **Diluted EPS** | -$0.49 | -$0.84 | -$6.63 | -$666.00 | -$1,526.00 | -$34.40 | -$53.60 | -$58.00 | -$190.00 | -$2.00 |
| Basic Shares Outstanding | 12.3M | 3.8M | 2.6M | 54.2K | 43.7K | 1.0M | 951.6K | 810.9K | 124.4K | 512.4K |
| Diluted Shares Outstanding | 12.3M | 3.8M | 2.6M | 54.2K | 43.7K | 1.0M | 951.6K | 810.9K | 124.4K | 512.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $4.03M | $2.84M | $1.66M | $1.90M | -$250K | $898K | $510K | $1.52M |
| Total Operating Expenses | $5.95M | $4.45M | $3.79M | $3.35M | $285K | $1.58M | $1.22M | $4.03M |
| **Operating Income** | -$5.95M | -$4.45M | -$3.79M | -$3.35M | -$285K | -$1.58M | -$1.22M | -$4.03M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$3.96M |
| Interest Expense | $100K | $100K | $100K | -- | $200K | $300K | $500K | -- |
| **Net Income** | -$5.54M | -$4.50M | -$3.75M | -$2.04M | -$351K | -$1.89M | -$1.71M | -$2.89M |
| Basic EPS | -$0.49 | -$0.66 | -$0.08 | -- | -$0.58 | -$5.45 | -$0.45 | -- |
| **Diluted EPS** | -$0.49 | -$0.66 | -$0.08 | -- | -$0.58 | -$5.45 | -$0.45 | -- |
| Basic Shares Outstanding | 11.4M | 6.8M | 48.2M | -- | 604.3K | 347.0K | 3.8M | -- |
| Diluted Shares Outstanding | 11.4M | 6.8M | 48.2M | -- | 604.3K | 347.0K | 3.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.79M | $111K | $1.13M | $19.21M | $42.27M | $24.67M | $22.49M | $48.61M | $24.05M | $13.36M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | $33.78M | -- | -- | -- |
| **Cash & Short-Term Investments** | $4.79M | $111K | $1.13M | $19.21M | $42.27M | $24.67M | $56.28M | $48.61M | $24.05M | $13.36M |
| **Total Current Assets** | $5.27M | $2.98M | $1.55M | $20.13M | $43.48M | $25.89M | $57.71M | $50.34M | $24.51M | $284K |
| Property, Plant & Equipment, Net | $0 | $0 | $35K | $169K | $216K | $133K | $201K | $248K | $278K | $51K |
| Other Non-Current Assets | -- | -- | -- | -- | -- | $30K | $113K | $129K | -- | -- |
| **Total Non-Current Assets** | $0 | $0 | $164K | $994K | $1.66M | $584K | $1.24M | $377K | $278K | $5.56M |
| **Total Assets** | $5.27M | $2.98M | $1.71M | $21.12M | $45.14M | $26.48M | $58.95M | $50.72M | $24.78M | $5.85M |
| Accounts Payable | $2.71M | $5.35M | $5.70M | $3.02M | $1.38M | $481K | $1.87M | $747K | $1.53M | $192K |
| Short-Term Debt | $1.00M | $6.52M | $2.22M | $3.98M | $0 | $5.24M | $4.34M | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $17.18M | $27.31M | $22.70M | $23.09M | $9.96M | $9.84M | $11.81M | $7.81M | $3.42M | $2.77M |
| Long-Term Debt | $0 | $0 | $1.61M | $8.56M | $12.00M | $6.38M | $10.50M | -- | -- | -- |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $0 | $0 | $1.61M | $8.69M | $12.80M | $6.41M | $10.93M | $0 | $0 | $2.20M |
| **Total Liabilities** | $17.18M | $27.31M | $24.31M | $31.78M | $22.75M | $16.25M | $22.73M | $7.81M | $3.42M | $4.97M |
| **Total Debt (incl. Leases)** | $1.00M | $6.52M | $3.97M | $13.38M | $13.46M | $12.04M | $15.76M | -- | -- | -- |
| Common Stock | $4.0K | $35K | $31K | $22K | $22K | $404K | $402K | $360K | $274K | $292K |
| Retained Earnings | -$300.6M | -$294.6M | -$291.4M | -$274.4M | -$238.3M | -$171.6M | -$137.0M | -$86.14M | -$38.96M | -$121.8M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | $18K | -- | -- | -- |
| **Total Stockholders' Equity** | -$11.91M | -$24.34M | -$22.60M | -$10.66M | $22.38M | $10.23M | $36.21M | $42.91M | $21.36M | $871K |
| Total Equity | -$11.91M | -$24.34M | -$22.60M | -$10.66M | $22.38M | $10.23M | $36.21M | $42.91M | $21.36M | $871K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $56.26M | $61.96M | $6.36M | $4.79M | $111K | $1.13M | $4.78M | $4.33M |
| **Cash & Short-Term Investments** | $56.26M | $61.96M | $6.36M | $4.79M | $111K | $1.13M | $4.78M | $4.33M |
| **Total Current Assets** | $58.26M | $63.39M | $8.50M | $5.27M | $2.98M | $1.55M | $5.63M | $5.38M |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $0 | $35K | $107K | $130K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $164K | $413K | $611K |
| **Total Assets** | $58.26M | $63.39M | $8.50M | $5.27M | $2.98M | $1.71M | $6.04M | $5.99M |
| Accounts Payable | $2.42M | $3.03M | $3.03M | $2.71M | $5.35M | $5.70M | $3.13M | $3.12M |
| Short-Term Debt | $0 | $0 | $0 | $1.00M | $6.52M | $2.22M | $2.82M | $2.28M |
| **Total Current Liabilities** | $17.19M | $16.97M | $16.09M | $17.18M | $27.31M | $22.70M | $23.47M | $21.25M |
| Long-Term Debt | -- | -- | -- | $0 | $0 | $1.61M | $2.62M | $3.33M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $1.61M | $2.62M | $3.34M |
| **Total Liabilities** | $17.19M | $16.97M | $16.09M | $17.18M | $27.31M | $24.31M | $26.09M | $24.59M |
| **Total Debt (incl. Leases)** | $0 | $0 | $0 | $1.00M | $6.52M | $3.97M | $5.76M | $6.11M |
| Common Stock | $41K | $40K | $51K | $4.0K | $35K | $31K | $31K | $25K |
| Retained Earnings | -$314.4M | -$308.8M | -$304.3M | -$300.6M | -$294.6M | -$291.4M | -$288.6M | -$285.0M |
| **Total Stockholders' Equity** | $41.07M | $46.42M | -$7.58M | -$11.91M | -$24.34M | -$22.60M | -$20.05M | -$18.60M |
| Total Equity | $41.07M | $46.42M | -$7.58M | -$11.91M | -$24.34M | -$22.60M | -$20.05M | -$18.60M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.00M | -$3.14M | -$17.05M | -$36.06M | -$66.73M | -$34.58M | -$50.87M | -$47.19M | -$21.21M | -$934K |
| Depreciation & Amortization | $0 | $35K | $113K | $77K | $114K | $68K | $87K | $216K | $39K | $44K |
| Stock-Based Compensation | $235K | $541K | $1.97M | $3.02M | $9.17M | $8.67M | $11.34M | $13.37M | $101K | $80K |
| Change in Receivables | $359K | -$359K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$2.63M | -$353K | $2.68M | $1.64M | -$320K | -$1.39M | $1.12M | -$780K | -$583K | $101K |
| **Operating Cash Flow** | -$6.33M | -$4.71M | -$14.34M | -$31.84M | -$35.00M | -$28.17M | -$39.39M | -$31.37M | -$15.94M | -$1.93M |
| Capital Expenditure | -- | -- | -- | -$66K | -$89K | -- | -$40K | -$235K | -$237K | -$2.5K |
| **Free Cash Flow** | -- | -- | -- | -$31.91M | -$35.09M | -- | -$39.43M | -$31.60M | -$16.17M | -$1.93M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -$67.21M | -- | -- | -- |
| **Investing Cash Flow** | $1.0K | $38K | $309K | -$66K | $2.06M | $33.79M | -$33.52M | -$317K | -$114K | $48K |
| Common Stock Issued | $0 | $0 | $3.15M | $0 | $47.72M | -- | $710K | $2.17M | $17.01M | $0 |
| Dividends Paid | -- | -- | -- | -- | -- | -- | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | $11.00M | $3.44M | -$4.08M | $8.81M | $50.79M | -$3.44M | $46.80M | $56.18M | $37.95M | $1.10M |
| **Net Change in Cash** | $4.67M | -$1.24M | -$18.11M | -$23.10M | $17.84M | $2.19M | -$26.11M | $24.50M | $21.90M | -$778K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.54M | -$4.50M | -$3.75M | -$2.04M | -$351K | -$1.89M | -$1.71M | -$2.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $73K |
| Stock-Based Compensation | $190K | $95K | $46K | $189K | $10K | $16K | $20K | $340K |
| Change in Payables | $176K | -$782K | $315K | -$683K | -$1.48M | -$336K | -$139K | $2.55M |
| **Operating Cash Flow** | -$4.28M | -$4.79M | -$5.45M | -$4.06M | -$1.72M | -$1.75M | $1.20M | -$2.01M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $51K |
| **Financing Cash Flow** | -$1.42M | $60.39M | $7.03M | $4.64M | $5.35M | $1.88M | -$865K | -$1.68M |
| **Net Change in Cash** | -$5.70M | $55.60M | $1.58M | $575K | $3.64M | $122K | $339K | -$3.64M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -38.8% | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -49.4% | -- | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -- | -298.1% | -338.0% | -140.5% | -110.0% | -99.3% | -107.2% |
| Return on Assets (ROA) | -113.8% | -105.6% | -996.1% | -170.7% | -147.8% | -130.6% | -86.3% | -93.0% | -85.6% | -16.0% |
| Current Ratio | 0.31x | 0.11x | 0.07x | 0.87x | 4.37x | 2.63x | 4.89x | 6.45x | 7.16x | 0.10x |
| Quick Ratio | 0.28x | 0.00x | 0.05x | 0.83x | 4.25x | 2.51x | 4.77x | 6.23x | 7.03x | 4.82x |
| Debt to Equity | -- | -- | -- | -- | 0.60x | 1.18x | 0.44x | -- | -- | -- |
| **Revenue Growth (YoY)** | -100.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -38.6% | -22.9% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -27.2% | -16.8% | -94.6% | -113.8% | -- | -- | -- | -996.1% |
| Current Ratio | 3.39x | 3.74x | 0.53x | 0.31x | -- | -- | -- | 0.07x |
| Quick Ratio | 3.27x | 3.65x | 0.40x | 0.28x | -- | -- | -- | 0.05x |
| Debt to Equity | 0.00x | 0.00x | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -552.9% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
